Compare MHO & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MHO | OPCH |
|---|---|---|
| Founded | 1976 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 1995 | 1996 |
| Metric | MHO | OPCH |
|---|---|---|
| Price | $151.96 | $24.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $160.00 | $36.57 |
| AVG Volume (30 Days) | 198.6K | ★ 2.6M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | ★ 5.57 | 0.29 |
| Revenue | $4,417,781,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $0.66 | $7.21 |
| Revenue Next Year | $6.97 | $8.55 |
| P/E Ratio | ★ $26.69 | $84.10 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $116.78 | $18.01 |
| 52 Week High | $163.66 | $36.80 |
| Indicator | MHO | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 64.49 |
| Support Level | $144.84 | $24.24 |
| Resistance Level | $155.40 | $24.96 |
| Average True Range (ATR) | 4.42 | 0.85 |
| MACD | -0.11 | 0.18 |
| Stochastic Oscillator | 52.33 | 84.11 |
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.